FDA Import Refusal SCS-0165694-2/11/1 — Pharmascience Inc.
The FDA refused shipment SCS-0165694-2/11/1 from Pharmascience Inc. (Canada) on Jun 27, 2018. The refused product falls under Drugs and Biologics — TADALAFIL. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 27, 2018
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 66SCY51 TADALAFIL
- Charges
- 75